eugenex产品代理
eugenex产品代理
在 EUGENEX Biotechnologies，我们为生物仿制药和新型生物制药的无动物成分 (ACF) 生产生成表达细胞系和工艺。我们的专有技术平台可提供出色的产量和高产品质量。通过我们在监管问题和生物安全方面的专业知识，我们的产品旨在简化 FDA 或 EMA 批准。目前，超过 12 种源自 EUGENEX 细胞系的生物药物为全世界的人们提供负担得起的高质量药物。
生物仿制药
即用型生物仿制药工艺
我们的 GeneXpress 系统提供现成的细胞系以及用于生物仿制药和新型生物制药商业生产的完整和部分流程。
技术平台
我们创新的 GeneXpress 系统
我们可靠的 CHOSI 宿主细胞系、无蛋白 MAM-PF 细胞培养基和高水平 pMOZ 表达质粒构成了我们的创新技术平台。
服务
满足您需求的定制解决方案
我们提供广泛的与临床前开发相关的内部服务，这些服务均以模块化方式提供，并可完全根据客户的需求进行定制。
我们的任务
在 EUGENEX Biotechnologies，我们设想了一个致力于可持续全球医疗保健的世界，我们热情地致力于通过我们的优质、节省成本的生产系统来实现这一愿景。我们与我们的客户和合作伙伴密切合作，旨在改善人们的生活并使每个人都能获得挽救生命的药物。
商业领域
从基因到产品
即用型生物仿制药工艺
细胞系和工艺开发服务
克级蛋白质生产和纯化服务（非 GMP）
分析和基于细胞的检测
技术转让和培训
除了生物仿制药开发、合同生产和我们自己的研究活动外，EUGENEX 还参与新药物的共同开发。
Your experienced partner for optimized cell lines and process development
At EUGENEX Biotechnologies, we generate expression cell lines and processes for the animal component-free (ACF) production of biosimilars and novel biopharmaceuticals. Our proprietary technology platform delivers excellent yields with high product quality. Through our expertise in regulatory issues and biosafety, our products are designed for a simplified FDA or EMA approval. Currently, more than 12 biopharmaceuticals derived from EUGENEX’ cell lines provide people worldwide with affordable, high-quality medicine.
Biosimilars
Ready-To-Go Biosimilar Processes
Our GeneXpress system offers ready-to-go cell lines as well as complete and partial processes for commercial manufacturing of biosimilars and novel biopharmaceuticals.
Technology Platform
Our Innovative GeneXpress System
Our reliable CHOSI host cell lines, protein-free MAM-PF cell culture media and high-level pMOZ expression plasmids form our innovative technology platform.
Services
Tailored Solutions For Your Needs
We offer a wide range of in-house services related to preclinical development that are all available on a modular basis and fully customizable to our clients' needs.
Our Mission
At EUGENEX Biotechnologies, we envision a world committed to sustainable global healthcare, and we passionately work to realize this vision with our quality, cost-saving production systems. Working closely with our customers and partners, we aim to improve people's lives and make life-saving medicine accessible to everyone.
Business Area
From Gene to Product
Ready-to-go Biosimilar processes
Gram scale protein production and purification services (non-GMP)
Analytical and cell-based assays
Technology transfer and training
In addition to biosimilar development, contract production and our own research activities, EUGENEX engages in the co-development of new pharmaceutical drugs.
